Skip to Main Content

COVID-19 Vaccination

Find a COVID-19 vaccination clinic

COVID-19 vaccines are safe and effective, and now available to Marylanders 12+.

Learn more about the vaccines here:

Please note:

  • We are only able to vaccinate people 18+ at most of our Health Department clinics. Only Pfizer is approved for people GE 12-17. (See below for resources for this age group and visit our COVID-19 Vaccines and Children page for more information.)
  • The Health Department is currently offering the Moderna vaccine and has limited supplies of the Johnson & Johnson/Janssen vaccine.
  • The Health Department currently schedules 1-3 first dose clinics each week.
  • Some of these clinics may be for targeted groups.
  • We will share clinic links online about 1-2 weeks before the scheduled date to allow anyone 18+ to register.
  • Registration links page 
  • Please note: Registration is preferred, but walk-ins will be permitted if vaccine supply allows. 
  • If you are 65+ or need assistance to register, please call our call center at 410-876-4848, Monday-Friday, 8 am – 5 pm. 
  • Si tiene 65 años o más o necesita ayuda para registrarse, llame a nuestro centro de llamadas al 410-876-4848, de lunes a viernes, de 8 a. M. A 5 p. M.

2nd doses: If you have received your 1st dose, make sure you register for an appointment to get your 2nd dose. If you entered an email when you registered for the 1st dose, you should receive an email to make an appointment for your 2nd dose. Check your spam folder. It will come from If you don’t have an email address, we will call you to set up your 2nd dose appointment. You can also just schedule your 2nd dose of Moderna in any clinic 28 days or more after your 1st dose clinic. Registration links page 

Other options for COVID-19 vaccination:

cases are rising - wear a mask, stay 6 feet apart, avoid crowds, get vaccinated when it's your turn

Johnson and Johnson COVID-19 vaccine:

Based on ACIP’s recommendations, the Maryland Department of Health (MDH) supports the reintroduction of the Johnson & Johnson vaccine. Maryland COVID-19 vaccine providers may resume using their available supplies of the Johnson & Johnson vaccine. “The Johnson & Johnson vaccine is one of our most important tools in the ongoing fight to prevent hospitalizations and deaths associated with COVID-19,” said Dr. Jinlene Chan, MDH’s deputy secretary for public health services. “By resuming use of this safe and effective vaccine in Maryland, we will continue to bolster our ability to stay ahead of new cases and emerging variants.”

As part of this reintroduction, providers should share with patients updated information about the potential risks related to the vaccine, including the rare occurrence of thrombosis with thrombocytopenia syndrome (TTS), a condition where a rare type of blood clot is found in combination with low platelet levels.

Federal agencies carefully reviewed reported events of TTS in patients who received the Johnson & Johnson COVID-19 vaccine. Out of nearly 8 million doses of the Johnson & Johnson COVID-19 vaccine administered, 15 cases of TTS have been identified. Most such cases occurred in females ages 18 through 49 years, with the onset of symptoms one to two weeks after vaccination. Three cases have resulted in fatalities. For women 50 years and older and men of all ages, this adverse event is even more rare.
MDH believes that, while it is important to understand the risks of any medical therapy, the benefits of COVID-19 vaccines outweigh the risks of TTS. Providers should carefully review the following information from CDC and FDA:

  • For three weeks after receiving the vaccine, you should be on the lookout for possible symptoms of a blood clot with low platelets. These include:
    • Severe or persistent headaches or blurred vision
    • Shortness of breath
    • Chest pain
    • Leg swelling
    • Persistent abdominal pain
    • Easy bruising or tiny blood spots under the skin beyond the injection site

Seek medical care right away if you develop one or more of these symptoms.

For more information:


Our COVID-19 vaccination survey is now closed. If you missed it, but still want to provide feedback, please contact 

Thank you to everyone who participated in our survey! See the vaccination survey results: COVID-19 Vaccination Survey data 12.8.2020